Skip to content

State of the art imaging and HCS platform

Imaging

Track your virus in real time infection thanks ANCHOR™ technology

We can offer different types of imaging and also image analysis whether in a viral or non-viral context, from high content imaging to high resolution imaging and light sheet microscopy.

We can indeed image many types of samples: 96-well plates, slides or spheroids. It is then possible to quantify different fluorescent markers of interest in an automated manner.

Our close collaboration with Imactiv-3D, a company specialized in imaging and image analysis, allows us to consider the use of complex 3D models from infected spheroids to insects.

Jean-Michel Lagarde
We are closely working with NeoVirTech as our partner on a wide range of imaging technologies. Together, we bring a comprehensive imaging platform ranging from the basic fluorescence, through the high content spinning-disk to lightsheet microscopy. That way, we can visualize 2D and 3D samples like infected spheroids. We also work together in image processing to design automatic and custom-made algorithms for quantification. NeoVirTech high-level expertise in virology combined with our know-how have led to reliable results allowing our clients to obtain unique endpoints.
Jean-Michel Lagarde
Imactiv-3D
Thursday, August 31, 2021
Marie PETIT
As Technology Transfer Accelerator Office, Sayens use to collaborate with technological companies having specific skills needed for our development programs. Thanks to its unique technology and comprehensive platform, NeoVirTech revealed been a highly competent company in antiviral drug evaluation for one of our program. I also really appreciate working with Dr. Franck Gallardo and his team, which were available at every step of the project, brought a strong expertise and a valuable follow up of the experiments.
Marie PETIT
Health and medical devices project manager at SAYENS
Thursday, August 31, 2017
Dr. Claire Bernhard
A strong partnership has been established between NeoVirtech and our lab (ICMUB, Dijon) in the frame of an innovative research program, supported by SATT SAYENS. Neovirtech’s team, headed by Dr. Franck Gallardo, was a key partner for project success, by providing a very strong expertise and high quality-service in the field of antiviral molecules development. A very appreciate added value, highlighting the benefit of public/private partnership for speeding up development program.
Dr. Claire Bernhard
CNRS Research engineer - Institute of Chemistry of the University of Burgundy
Thursday, August 31, 2017
Dr Daniel Gillet
We are developing inhibitors of intracellular trafficking pathways that block virus entry into cells. NeoVirTech’s technology allows for precise ranking of sets of analogues according to their antiviral potencies and selectivity indexes. Working with NeoVirTech was a great experience. Preparatory discussions were rich and efficient, adaptation of protocols to our needs was very successful, antiviral screening of our molecules was done rapidly, and activity reports were clear and informative. The team was always available to answer our questions. We warmly recommend NeoVirTech for the screening and potency assessment of antiviral molecules on designated viruses.
Dr Daniel Gillet
Frédéric Joliot Institute for Life Sciences, CEA Paris Saclay
Thursday, August 31, 2017
Dr Lucile Tran
The Technology Transfer Office Aquitaine Science Transfert (AST) aims to accelerate the dissemination of innovations on the market. AST supports innovative concepts from the researcher’s invention until proof-of-concept has been established. For a project of our portfolio, we were looking for a partner to evaluate the antiviral activity of a patented compound on infection and replication of different virus families. We had efficient and productive interactions with Dr Franck Gallardo and his team throughout the project to design the study, plan the execution and discuss about the results. I would highly recommend Neovirtech for antiviral drug evaluation.
Dr Lucile Tran
Healthcare project manager – Business Developer at Aquitaine Science Transfer
2021